Sepsis, the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) are the most common causes of death in noncardiac intensive care units in the United States and Europe (1). To date, the pathophysiologic alterations underlying the organ-system abnormalities in these disorders are unknown. Cardiovascular dysfunction, involving both systolic and diastolic abnormalities, is frequently noted in sepsis, SIRS, and MODS (2). Key among the characteristic abnormalities is ventricular dilatation and depressed contractility. The latter is manifest clinically as a decrease in ejection fraction with a requirement for high levels of preload to maintain normal stroke volume (3). Although a number of mediators and pathways have been shown to be associated with myocardial depression in sepsis, a unifying cause has yet to be found. Because a decrease in bioenergy available for contraction is a potential etiology, prior work has evaluated high-energy phosphate levels in a number of tissues. Some investigators have found preserved cardiac and skeletal muscle ATP levels during sepsis (4–8). Other studies demonstrated decreases in myocardial ATP and skeletal myocyte phosphocreatine levels (6,9,10). However, none of these studies has directly examined the integrity of the process of mitochondrial respiration. Because one hallmark of sepsis is an inability to consume or use molecular oxygen, it has been proposed that a defect in oxidative phosphorylation underlies sepsis-associated organ dysfunction (11).
The process of oxidative phosphorylation involves the oxidation of NADH and FADH2 generated by the Krebs cycle and the β-oxidation of fatty acids. This is catalyzed by a series of five enzyme complexes that comprise the respiratory chain on the mitochondrial inner membrane. In this process, electrons are transported from one enzyme to the next to ultimately generate ATP. Proton pumps within complexes I, III, and IV maintain a transmembrane hydrogen ion gradient that is integral to ATP generation. Dysfunction of any of the five complexes could impair oxidative phosphorylation and reduce the potential energy of the system. In the setting of sepsis, the enzyme complex most intriguing to study is complex IV, also called cytochrome c oxidase. Cytochrome c oxidase is the terminal oxidase in the electron transport system. It catalyzes the reduction of molecular oxygen to water using electrons from reduced cytochrome c generated by complex III. The consumption of oxygen in this process is closely linked to proton pumping across the inner mitochondrial membrane. Complex V then uses the trans-membrane proton gradient for ATP generation. Because of the documented defect in oxygen extraction in sepsis, examination of the kinetic activity of complex IV is logical. Therefore, in this study, we test the hypothesis that sepsis, induced by cecal ligation and puncture (CLP) in mice, alters the kinetics of cytochrome c oxidation by complex IV.
Cytochrome c oxidase contains 13 subunits. Subunit I, the active site, catalyzes the key activity of the complex via the heme a,a3 binuclear center. Electrons from reduced cytochrome c are transferred from the divalent copper center in subunit II to the heme a center of subunit I and are then turned over to the heme a3 center, where oxygen is reduced to water. Previous studies have demonstrated that sepsis alters transcription in a number of tissues (12–14). Because the major activities of cytochrome c oxidase are performed by subunit I, we chose to test the secondary hypothesis that sepsis impairs the expression of subunit I of cytochrome c oxidase and the abundance of heme a,a3.
MATERIALS AND METHODS
Induction of sepsis
All animal studies were approved by the University Laboratory Animal Resources committees at the University of Pennsylvania and conformed to National Institutes of Health standards. Under isoflurane general anesthesia, 6- to 8-week-old male C57B1/6 mice (Charles River Laboratories, Boston, MA) underwent sham operation, single-puncture CLP (CLP), or double-puncture CLP (2CLP) as previously described (12–17). In the sham-operated mice, the cecum was manipulated but was not ligated or punctured. Punctures in CLP and 2CLP were performed with a 23-gauge needle. All animals were administered 50 mL/kg saline subcutaneously immediately postprocedure and then every 24 h. Once awake, animals were given access to food and water ad libitum. Animals were sacrificed at 0, 3, 6, 16, 24, or 48 h postprocedure. Three mice per time point per group were studied. Because of the mortality associated with 2CLP (50% at 24 h, 75% at 48 h, and 90% at 72 h), six mice were randomized to the 2CLP 24-h group and 12 mice were designated as 2CLP 48-h time points. Under deep pentobarbital anesthesia (50 mg/kg) and before apnea, the heart was excised and cardiac ventricles were harvested immediately. RNA was isolated in a separate group of animals.
Cytochrome c oxidase steady-state kinetics
Cardiac ventricles were homogenized in H medium (70 mM sucrose, 220 mM mannitol, 2.5 mM HEPES, pH 7.4, and 2 mM EDTA). Mitochondria were isolated by differential centrifugation and mitochondrial protein concentration was determined (18).
Cytochrome c oxidase kinetics were assayed by the method of Smith in which the rate of oxidation of ferrocytochrome c is measured by following the decrease in absorbance at 550 nm (18,19). Assays were executed in a 1-mL reaction volume containing 50 mM PO4−2 (pH 7.0), 2% lauryl maltoside, and 0.5 μg of mitochondrial protein. Ferrocytochrome c was added at concentrations of 80, 40, 20, 10, 5, and 2 mM to initiate the reaction. First-order rate constants were calculated from mean values of three to four measurements at each ferrocytochrome c concentration. Specific activities were calculated using 21.1 mM−1 cm−1 as the extinction coefficient of ferrocytochrome c at 550 nm and Lineweaver-Burk plots were constructed. Vmax values were determined from the y axis intercepts and Km values were determined from the x axis intercepts.
Measurement of heme a,a3 content
Mitochondria were isolated from cardiac ventricles via differential centrifugation. Mitochondrial heme a,a3 content was calculated from the difference in spectra (dithionate/ascorbate reduced minus ferricyanide oxidized) of mitochondria solubilized in 10% lauryl maltoside using an absorption coefficient of 24 mM−1 cm−1 at 605 to 630 nm as described by Vijayasarathy et al. (18).
Northern blot hybridization of cytochrome c oxidase subunit I
Total RNA was extracted from cardiac tissue using the method of Chomczynski and Sacchi (20). As previously described (12–14,17,21), 10 μg of denatured RNA was resolved by electrophoresis on 1.5% formaldehyde-containing agarose gels. Gels were transferred to nylon membranes and were hybridized against purified, double-stranded 32P-labeled cytochrome oxidase subunit I cDNA probes. Autoradiography and phosphorimaging were performed and data were normalized to the density of the 18S ribosomal subunit.
10-μg samples of mitochondrial protein were subjected to SDS-acrylamide gel electrophoresis and immunoblotting as previously described (13). Blots were labeled with a primary polyclonal antibody to mouse cytochrome c oxidase subunit I (Molecular Probes, Eugene, OR) and were secondarily exposed to rabbit anti-mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA). The signal was detected with enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech, Piscataway, NJ), and density was measured using scanning densitometry.
Three animals per time point were evaluated. Data is presented as the mean ± standard deviation. Best-fit linear regression was applied to each Lineweaver-Burk plot. Statistical significance was assessed using the student's test with P < 0.05.
Cytochrome c oxidase inhibition
Data from steady-state kinetic assays were used to construct Lineweaver-Burk plots for different time points after sham operation, CLP, and 2CLP. These plots for 6, 16, 24, and 48 h postintervention are depicted in Figure 1. After sham (blue) and CLP (black), the slope of the best-fit line and Km increased at 6, 16, and 24 h compared with baseline (time zero, nonoperative control, green line). Vmax, however, remained unchanged throughout. For both, this represented a pattern of competitive (reversible) inhibition. By 48 h after sham operation, slope and Km returned to baseline. Beginning 24 h after CLP, slope and Km moved toward, but never reached, baseline values. Results after 2CLP were quite different (red lines). Up to 24 h after 2CLP, slope and Km increased in a manner similar to that observed after sham operation and CLP, consistent with competitive inhibition. At 48 h, however, whereas the slope remained increased and the Km approached baseline, Vmax significantly decreased (Table 1). This represented a pattern of noncompetitive or irreversible inhibition.
Heme a,a3 content decreases late in sepsis
One explanation for irreversible inhibition is the destruction of the heme catalytic center leading to decreased binding in a manner that cannot be reversed. Therefore, heme a,a3 content in cytochrome c oxidase subunit I was examined. Heme a,a3 content decreased significantly 48 h after 2CLP (Fig. 2), whereas values after sham operation and CLP were unchanged.
Steady-state levels of cytochrome c oxidase subunit I decrease in sepsis
Previous studies in liver have demonstrated a persistent decrease in the expression of key proteins in liver and lung after 2CLP (12–14,16,17). Persistently decreased expression of subunit I could also explain the alteration in Vmax observed at 48 h after 2CLP. Therefore, Northern blot analysis was used to examine steady-state levels of mRNA encoding subunit I (Fig. 3). After sham operation, there was a transient decrease in subunit I mRNA levels 3 h after intervention. From 6 h onward, levels after sham operation were equivalent or higher than values at T0. After CLP, mRNA levels decreased but returned to baseline by 16 h after operation. This is similar to observations in the liver (12–14,16,17). In contrast, steady-state levels of subunit I mRNA decreased and remained depressed at all time points after 2CLP. Again, this is consistent with observations in lung and liver (12–14,16,17).
Protein expression parallels changes in mRNA
For altered steady-state mRNA levels to be meaningful, protein levels must be altered also. Therefore, immunoblotting was used to examine cytochrome c oxidase subunit I abundance (Fig. 4). After sham operation, levels decreased early and approached baseline by 24 h. The decrease in levels after CLP and 2CLP was persistent and more pronounced in double-puncture animals during the late phase (Fig. 4).
The studies presented here reveal a fundamental, sepsis-associated biochemical defect in the mitochondrial pathway that leads to the reduction of molecular oxygen to water and the production of high-energy phosphates. We demonstrate explicitly, in myocardial tissue, an irreversible, noncompetitive block in the ability of cytochrome c oxidase, complex IV in the electron transport chain, to use cytochrome c late in fulminant sepsis. This correlates with a loss of the catalytic heme a,a3 moiety and a decrease in the abundance of subunit I of cytochrome c oxidase, where this heme group resides. Furthermore, these findings correlate with decreased expression of the gene encoding subunit I. These results corroborate work done by Wei and coworkers (23) that demonstrated nitric oxide-dependent decreases in cytochrome oxidase subunit I mRNA and protein in lipopolysaccharide-treated macrophages. Our findings have important implications with regard to sepsis-associated myocardial dysfunction and perhaps failure in the other organ systems affected by the disorder.
In previous studies, we and others have used the CLP model in rodents to investigate a number of sepsis-associated abnormalities in different organ systems (15,17,24). After CLP, mice and rats develop inflammation, but recovery is the rule (14,17,21). In contrast, 2CLP results in a predictable mortality of 50% at 24 h, 75% at 48 h, and 85% to 90% at 72 h postprocedure (17,21). Chaudry and coworkers (25) have characterized cardiodynamic dysfunction in this model, showing that, up to about 20 h after 2CLP, cardiac output is increased. At subsequent time points, however, contractility and cardiac output decline. These sepsis-associated alterations in cardiac performance are well documented, but the etiology of the hypodynamic state remains obscure. Our findings offer a potential explanation: an initial reversible and later irreversible inability to generate the energy required for contraction and cellular homeostasis. In addition, although the cause of death in this model of sepsis is unknown, several investigators have speculated that it is secondary to cardiovascular collapse (26). The irreversible defect in myocardial ATP generation late in the course of severe sepsis correlates temporally with the development of late myocardial depression, supporting this proposal. Indeed, the irreversible impairment in cytochrome c oxidase function and, as a result, in ATP generation, also correlates with the high mortality seen after 2CLP and contrasts with the recovery characteristic of CLP.
One limitation of our work is the lack of a functional correlate to the kinetic abnormalities and alterations in expression of cytochrome oxidase we have reported. Chaudry's work (25,27) compared 2CLP with SO in rats and mice at 5 and 20 h postprocedure. This work has been generally accepted and universally cited. Because our methodology duplicates that of Chaudry et al. almost exactly, we believe that the function should be the same. Nevertheless, it will be important to demonstrate a correlation between altered activity and expression of cytochrome oxidase and cardiac performance at each time point after 2CLP, CLP, and SO.
There are several potential explanations for a decrease in the Vmax for cytochrome c oxidase 48 h after 2CLP. We specifically investigated two of them. Because we examined specific activity per milligram of total mitochondrial protein, a decrease in the quantity of enzyme as a component of mitochondrial protein could explain the alteration. This is borne out by data on steady-state levels of subunit I mRNA and protein. Alternatively, the change in Vmax could result from the generation and binding of a noncompetitive or irreversible inhibitor. Such irreversible inhibitors of cytochrome c oxidase include carbon monoxide (CO), cyanide (CN−), lipid peroxidation due to reactive oxygen species, and peroxynitrite. Increases in CO, reactive oxygen species, and peroxynitrite have been reported in sepsis (28–30). A recent study has identified a mechanism for endogenous CN− generation in the brain, but this has not been extended to myocardium (31). In sepsis, heme oxygenase-1 (HO-1) is induced and leads to the generation of CO by catalyzing the breakdown of heme to CO and biliverdin (32–34). The active site of cytochrome c oxidase, containing a heme a,a3, could certainly be a target of HO-1 in sepsis. Similarly, reactive oxygen species directly peroxidize lipids and have the potential to destroy the functional integrity of cytochrome c oxidase. The net effect of these destructive processes would be a decrease in the quantity of heme a,a3 and/or cytochrome c oxidase as a result of degradation. The data in Figures 2 and 4 support this. Alternatively, our previous studies on lung and liver after 2CLP have revealed a decrease in the expression of key proteins (12–14,16,17). Failure to express subunit I of cytochrome c oxidase, as demonstrated here (Fig. 3), would also lead to decreased enzyme levels and activity. This also is consistent with previous findings in liver and lung. Thus, our findings support a loss of the active subunit of cytochrome c oxidase and, in particular, of the heme a,a3 center, as a potential cause of failed enzyme activity. It should be pointed out that the gene encoding Complex IV subunit I is found in mitochondrial DNA. Therefore, the data presented here represent a unique example of an alteration in expression of mitochondrial DNA in the setting of an acute disease.
Prior studies of cardiac dysfunction in sepsis have measured ATP levels in dysfunctional myocytes. The results are difficult to interpret. However, the decreased ability to aerobically generate ATP, as would result from destruction of cytochrome c oxidase, need not result in a loss of ATP. If an alternative mechanism for ATP production exists, contractility and homeostasis, although depressed, could be maintained. Furthermore, if cardiomyocyte metabolism becomes down-regulated, contractility would decrease due to decreased energy consumption with preservation of ATP levels. Indeed, the decrease in contractility observed in sepsis might represent a mechanism to preserve high-energy phosphate levels. A process whereby cardiomyocyte metabolism becomes down-regulated with decreased contractility and preserved ATP levels has been observed in hypoxia and ischemia (22). This process has been termed “myocardial hibernation.” In fact, it has been hypothesized that cytochrome c oxidase is the “sensor” that initiates hibernation in the face of decreased oxygen delivery to the mitochondria (22). This process could well be occurring in sepsis.
Similar dysfunction in tissues other than the heart could easily reflect a loss of integrity of mitochondrial function. For example, we have recently demonstrated regenerative failure in the liver of septic mice (35). Regeneration would clearly be compromised by a defect in oxidative phosphorylation. Further studies will examine specific etiologies of myocardial cytochrome c oxidase impairment, examine other enzymes in the pathway, and seek to demonstrate a defect in other organ systems. A unified mechanism to explain the diverse abnormalities observed in sepsis, which has thus far eluded identification, may emerge.
1. Davies MG, Hagen PO: Systemic inflammatory response syndrome. Br J Surg 84:920–935, 1997.
2. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock. Crit Care Clinics 16:251–287, 2000.
3. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Internal Med 113:227–242, 1990.
4. Hotchkiss RS, Rust RS, Dence CS, Wasserman TH, Song SK, Hwang DR, Karl IE, Welch MJ: Evaluation of the role of cellular hypoxia in sepsis
by the hypoxic marker [8F]fluoromisonidazole. Am J Physiol 260:R965–R967, 1991.
5. Solomon MA, Correa R, Alexander HR, Koev LA, Cobb JP, Kim DK, Roberts WC, Quezado ZM, Scholz TD, Cunnion RE: Myocardial energy metabolism and morphology in a canine model of sepsis
. Am J Physiol 266:H757–H768, 1994.
6. Song SK, Hotchkiss RS, Karl IE, Ackerman JJ: Concurrent quantification of tissue metabolism and blood flow via 2H/31P NMR in vivo. III. Alterations of muscle blood flow and metabolism during sepsis
. Magn Reson Med 25:67–77, 1992.
7. Jacobs DO, Maris J, Fried R, Settle RG, Rolandelli RR, Koruda MJ, Chance B, Rombeau JL: In vivo phosphorus 31 magnetic resonance spectroscopy of rat hind limb skeletal muscle during sepsis
. Arch Surg 123:1425–1428, 1988.
8. Jepson MM, Cox M, Bates PC, Rothwell NJ, Stock MJ, Cady EB, Millward DJ: Regional blood flow and skeletal muscle energy status in endotoxemic rats. Am J Physiol 252:E581–E587, 1987.
9. Raymond RM, Gordey J: The effect of hypodynamic endotoxin shock on myocardial high energy phosphates in the rat. Cardiovasc Res 23:200–204, 1989.
10. Jacobs DO, Kobayashi T, Imagire J, Grant C, Kesselly B, Wilmore DW: Sepsis
alters skeletal muscle energetics and membrane function. Surgery 110:318–326, 1991.
11. Fink M: Cytopathic hypoxia in sepsis
. Acta Anaesth Scand Supp 110:87–95, 1997.
12. Deutschman CS, Andrejko KM, Haber BA, Bellin L, Elenko E, Harrison R, Taub R: Sepsis
-induced depression of rat glucose-6-phosphatase gene expression
and activity. Am J Physiol 273:R1709–R1718, 1997.
13. Weiss YG, Bouwman A, Gehan B, Schears G, Raj N, Deutschman CS: Cecal ligation and double puncture impairs heat shock protein 70 (HSP-70) expression in the lungs of rats. Shock 13:19–23, 2000.
14. Andrejko KM, Deutschman CS: Altered hepatic gene expression
in fecal peritonitis: changes in transcription of gluconeogenic, β-oxidative, and ureagenic genes. Shock 7:164–169, 1997.
15. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis
on tissue adenine nucleotide levels. Surgery 85:205–211, 1979.
16. Deutschman CS, DeMaio A, Buchman TG, Clemens MG: Sepsis
-induced alterations in phospho enol
pyruvate carboxykinase expression: the role of insulin and glucagon. Circ Shock 40:295–302, 1993.
17. Andrejko KM, Chen J, Deutschman CS: Intrahepatic STAT-3 activation and acute phase gene expression
predict outcome after CLP sepsis
in the rat. Am J Physiol 275:G1423–G1429, 1998.
18. Vijayasarathy C, Biunno I, Lenka N, Yang M, Basu A, Hall IP, Avadhani NG: Variations in the subunit content and catalytic activity of the cytochrome c oxidase complex from different tissues and different cardiac compartments. Biochim Biophys Acta 1371:71–82, 1998.
19. Smith L: Spectrophotometric assay of cytochrome c oxidase. Methods Biochem Anal 2:427–434, 1955.
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987.
21. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis
in a murine cecal ligation and puncture model. Surgery 94:331–335, 1983.
22. Budinger GR, Durante J, Chandel NS, Schumaker PT: Hibernation during hypoxia in cardiomyocytes. Role of mitochondria
as the O2
sensor. J Biol Chem 273:3320–3326, 1998.
23. Wei J, Guo H, Kuo PC: Endotoxin-stimulated nitric oxide production inhibits expression of cytochrome c oxidase in ANA-1 murine macrophages. J Immunol 168:4721–4727, 2002.
24. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724–2730, 1992.
25. Yang S, Cioffi WG, Bland KI, Chaudry IH, Wang P: Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis
. J Trauma Injury Infect Crit Care 47:706–712, 1999.
26. Fowler DE, Wang P: The cardiovascular response in sepsis
: proposed mechanisms of the beneficial effect of adrenomedullin and its binding protein. Int J Mol Med 9:443–449, 2002.
27. Yang S, Chung CS, Ayala A, Chaudry IH, Wang P: Differential alterations in the cardiovascular response during progression of polymicrobial sepsis
in the mouse. Shock 17:55–60, 2002.
28. Yet SF, Pellacani A, Patterson C, Tan L, Folta SC, Foster L, Lee WS, Hsieh CM, Perrella MA: Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem 272:4295–4301, 1997.
29. Callahan LA, Stofan DA, Szweda LI, Nethery DE, Supinski GS: Free radicals alter maximal diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis
. Free Radic Biol Med 30:129–138, 2001.
30. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS: Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 25:812–819, 1997.
31. Gunasekar PG, Borowitz JL, Turek JJ, Van Horn DA, Isom GE: Endogenous generation of cyanide in neuronal tissue: involvement of a peroxidase system. J Neurosci Res 61:570–575, 2000.
32. Lyoumi S, Puy H, Tamion F, Scotte M, Daveau M, Nordmann Y, Lebreton JP, Deybach JC: Nitric oxide synthase inhibition and the induction of cytochrome P-450 affect heme oxygenase-1 messenger RNA expression after partial hepatectomy and acute inflammation in rats. Crit Care Med 26:1683–1689, 1998.
33. Otani K, Shimizu S, Chijiiwa K, Morisaki T, Yamaguchi T, Yamaguchi K, Kuroki S, Tanaka M: Administration of bacterial lipopolysaccharide to rats induces heme oxygenase-1 and formation of antioxidant bilirubin in the intestinal mucosa. Digestive Dis Sci 45:2313–2319, 2000.
34. Suzuki T, Takahashi T, Yamasaki A, Fujiwara T, Hirakawa M, Akagi R: Tissue-specific gene expression
of heme oxygenase-1 (HO-1) and non-specific δ-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome. Biochem Pharm 60:275–283, 2000.
35. Weiss YG, Bellin L, Kim PK, Andrejko KM, Haaxma CA, Raj N, Furth EE, Deutschman CS: Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis
in rats. Am J Physiol Gastrointest Liver Physiol 280:G968–G973, 2001.